Maresin1 alleviates inflammation and improves extracellular matrix regeneration after intervertebral disc degeneration
Cellular Signalling · 2026
DOI: 10.1016/j.cellsig.2026.112803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Hui Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Zhejiang, China; Department of Orthopedics, The Secon…. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Intervertebral Disc Degeneration, Extracellular Matrix, Inflammation. Die Arbeit nennt 66 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is characterized by excessive inflammation and extracellular matrix (ECM) degradation in the nucleus pulposus (NP), with limited current therapeutic options. Specialized pro-resolving mediators (SPMs) such as Maresin 1 (MaR1) have emerged as key regulators of inflammation resolution and tissue repair. Here, we report that MaR1 and its receptor LGR6 are significantly downregulated in degenerated human NP tissues, suggesting a loss of endogenous resolution capacity. Exogenous MaR1 administration effectively attenuated IL-1β-induced inflammation and ECM degradation in human NP cells and alleviated IVDD progression in rat models. Mechanistically, MaR1 simultaneously suppressed the catabolic AP-1/MMP pathway and activated the pro-anabolic OSR1/GDF7 axis, rebalancing ECM homeostasis. Notably, the therapeutic efficacy of MaR1 was completely abrogated in Lgr6-knockout mice, demonstrating that LGR6 is the indispensable mediator of MaR1's protective effects in vivo. Our findings identify the MaR1-LGR6 axis as a critical regulator of disc homeostasis and highlight MaR1 supplementation as a novel and promising strategy for IVDD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou Zhejiang, China; Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medica…
- Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Precision Anesthesiology Key Laboratory of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang, China; Institute of Autoimmune Diseases, Sc…
- Key Laboratory of Pediatric Anesthesiology, Ministry of Education, Precision Anesthesiology Key Laboratory of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Institute of Autoimmune Diseases, School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- Department of Orthopedics, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Zhejiang Provincial Key Laboratory of Orthopedics, Wenzhou, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Wang, H., Li, X., Yan, T., He, P., Yao, J., Wang, J., Su, L., Wu, A., Jin, S., Wang, J., & Lv, C. (2026). Maresin1 alleviates inflammation and improves extracellular matrix regeneration after intervertebral disc degeneration. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112803
Vancouver
Wang H, Li X, Yan T, He P, Yao J, Wang J, et al. Maresin1 alleviates inflammation and improves extracellular matrix regeneration after intervertebral disc degeneration. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112803
BibTeX
@article{Wang2026,
author = {Wang, Hui and Li, Xiangyu and Yan, Tao and He, Panwei and Yao, Junxiang and Wang, Jinhui and Su, Lele and Wu, Aimin and Jin, Shengwei and Wang, Jianguang and Lv, Chen},
title = {Maresin1 alleviates inflammation and improves extracellular matrix regeneration after intervertebral disc degeneration},
journal = {Cellular Signalling},
year = {2026},
doi = {10.1016/j.cellsig.2026.112803}
}
EUVIMED